GlassScriptPhysician profile
Glen S Bartlett
NPI 1134190390
$544.83
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $154.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $100.96 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $82.92 | 2019 | |
| Sage Therapeutics, LLC | $69.56 | 2020 | |
| Pfizer INC. | $46.92 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $46.07 | 2019 | |
| Tris Pharma INC | $41.49 | 2019-2020 | |
| Sanofi Pasteur INC. | $36.72 | 2019 | |
| Sobi, INC | $36.68 | 2019 | |
| Dermira, INC. | $36.52 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.64 | 2019 | |
| Kaleo, INC. | $15.49 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Bartlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.